A novel cMET inhibitor, MK8033, potentiates the activity of carboplatin/paclitaxel in ovarian cancer cell lines

✍ Scribed by Marchion, D.; Ramirez-Diaz, I.; Bou Zgheib, N.; Xiong, Y.; Stickles, X.; Judson Lancaster, P.; Gonzalez Bosquet, J.; Wenham, R.; Apte, S.; Lancaster, J.

• Book ID: 123542662
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 59 KB
• Volume: 130
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2013.04.375